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Abstract
Objectives: The aim of this study was to assess association of the -1082 IL-10 gene polymorphism with chronic 
periodontitis CP in a Peruvian population.
Study Design: Samples of venous blood and DNA were obtained from 106 Peruvian subjects: a) 53 periodontally 
healthy; and b) 53 with CP. The association of the -1082 IL-10 promoter sequences was assessed by Polymerase 
chain reaction-restriction fragment length polymorfism (PCR-RFLP). Student’s t test were used to assess the clini-
cal parameters, as well as the χ2 test and the odds ratio (OR), with 95% confidence intervals (CI) used performed 
for estimates regarding genotype and allele frequencies.
Results: There were statistically significant differences between groups regarding the mean bleeding on probing, 
mean attachment level and mean probing depth (p < 0.00001) indicating that the matching based on the evaluated 
groups was adequate. The χ2 test found a statistically significant imbalance of genotypes between groups (p = 
0.0172). The prevalence of CP was significantly higher in subjects harboring at least one A allele at position -1082 
(AA and GA genotypes) in comparison to patients with the GG genotype (OR = 2.96; CI: 0.52; 5.41; p = 0.0099). 
Equally, subjects with the AA genotype were significantly associated to a diagnosis of CP (OR = 2.71; CI: 0.38; 
5.04; p = 0.0231). On the other hand, subjects presenting a healthy periodontal status presented at least one G allele 
in comparison with the AA genotype (OR = 0.37; CI: 0.05, 0.69; p = 0.0231). For subjects with the GG genotype, 
the same positive association was observed (OR = 0.34; CI: 0.06, 0.62; p = 0.0099). There were no significant dif-
ferences between groups amongst subjects with the GA genotype (OR = 1.19; CI: 0.22, 2.16; p = 0.6774). 
Conclusions: Within the limits of this study, IL-10 gene polymorphism at position -1082 does not appear to be as-
sociated to CP. Conversely, subjects with AA genotype seem to be at an increased risk of developing CP.
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kin-10, periodontal disease.
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Introduction
Chronic periodontitis (CP) is a multifactorial disease in 
which the dental biofilm is the key trigger for the ini-
tiation of the inflammation process (1,2). Differently of 
other forms of periodontal disease, the rate of progres-
sion of the disease (i.e. periodontal tissues loss) is slow 
to moderate, and it is commonly associated with the 
presence of the aetiological agent (3,4).
It has been demonstrated that biofilm-induced inflam-
mation leads to a sequence of innate and modified im-
mune host responses, that stimulates the production of 
cytokines and chemokines, and that may be modulated 
by genetic factors (5,6). Among these inflammatory me-
diators, interleukin-10 (IL-10) has been considered and 
important contributor to the pathogenesis of periodontal 
diseases (5-7). IL-10 is a fundamental cytokine involved 
in the infection’s regulatory processes (for some T-cell 
subgroups), as well as it precludes for autoimmunity be-
cause of the tolerance to self-antigens (5). As a result, it 
plays a role on: 1) suppressing macrophages and other 
important cells; 2) controlling the inflammation; and 3) 
preventing tissue breakdown (5,7-10). 
With respect to the role of genetic predisposition (GP), a 
couple of studies performed on twin brothers found that 
GP can increase the risk of CP (11,12), as well as GP has 
been linked to the capacity of producing IL-10 (13,14). 
Located on chromosome 1q31-q32, IL-10 gene presents 
diverse discrepancies in the promoter region that leads 
to dissimilarities on the production of the related-anti-
inflammatory citokine, and to consequent modifications 
of the inflammatory processes (13,14). Together with 
the plausibility of genetic polymorphisms (GP) of IL-
10 influencing different conditions of the body, it has 
been reported the possible influence of gene expression 
in regulating CP (15-18). On the other hand, additional 
studies failed to support the association of GP and peri-
odontitis (19,20). 
Another study on the prevalence of interleukin-1 peri-
odontal genotype in a Hispanic dental population, 
Caffesse et al. found a genotype positive prevalence of 
26% (21). This same group studied the effect of inter-
leukin-1 GP in a periodontally healthy Hispanic popu-
lation treated with mucogingival surgery. In this study 
22 subjects who were treated for class I and class II 
recession-type defects were evaluated for the response 
to mucogingival surgery on a population with a 26% 
genotype positive prevalence. Results indicated that 5 
out of 22 subjects were genotype positive. Treatment 
of the localized recessions provided similar amount of 
coverage in genotype positive and negative subjects. 
They concluded that periodontal health can be main-
tained with proper preventive maintenance irrespective 
of the genotype present (22).
Despite of these surveys conducted in different popula-
tions, there have been few studies focusing on the influ-
ence of IL-10 GP among Latin-American populations, 
and none on Peruvian (Amerindian-Spanish) subjects, 
in terms of CP regulation. Thus, the purpose of this 
study was to assess association of the -1082 IL10 GP 
with CP.
Material and Methods
- Study design and population
One hundred and six systemically healthy, non-smok-
ing subjects, 40 male and 66 female, 20 to 74 years 
old (mean age: 43.4 years), participated in this cross-
sectional study. These subjects were selected from an 
initial sample of 800 patients who were referred for 
dental treatment at the dental clinic of Científica del 
Sur University between July 2012 and March 2013. The 
protocol of the study was prepared according to The 
Strengthening the Reporting of Observational Studies 
in Epidemiology (STROBE) statement (23). It was ap-
proved by the Ethics on Research Committee of Faculty 
of Dentistry, Científica del Sur University, and was con-
ducted in accordance with the Helsinki Declaration of 
1964 as revised in 2008. The subjects participating in 
the study were volunteers who received detailed infor-
mation regarding the proposed research and provided 
signed consent. 
- Inclusion and exclusion criteria
The subjects were enrolled in the study when the fol-
lowing inclusion criteria were met: 1) age > 20 years; 
2) at least 15 teeth, excluding third molars; and 3) a 
non-smoking status. All consecutive patients who met 
these inclusion criteria were invited to take part in the 
study. Patients with a diagnosis of aggressive periodon-
titis, a known systemic disease (e.g., acquired immuno-
deficiency syndrome [AIDS], diabetes mellitus, blood 
disease problem), pregnant/lactate, who were submitted 
to periodontal therapy in the previous 12 months, or 
antimicrobial, anti-inflammatory and immunosuppres-
sive therapies during the previous 6 months were not 
included in the study.
- Sample size calculation 
Sample size was calculated considering a two-sided 
significance level of 5%, a power of 80%, the propor-
tion of subjects with CP in the non-exposed group of 
38% and proportion of subjects with CP in the exposed 
group (i.e. AA -1087 Genotype) of 69%, based on a re-
cent study (7). Considering the Fleiss method  with con-
tinuity correction factor, a sample size of 47 per group 
would be necessary.
- Clinical examination and experimental groups
Full medical and dental histories were obtained. Data in-
cluded full mouth probing depth (PD) measured at six 
sites around teeth, clinical attachment level (CAL) and 
bleeding on probing (presence or absence) using a UNC-
15 periodontal probe recorded by two trained and cali-
brated periodontists (GM and LP) (intraclass correlation 
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coefficient > 0.82 for PD and CAL). Patients without a 
history of periodontitis and no sites with PD and CAL 
> 3 mm concomitantly were included in the periodon-
tally healthy group (Group H; n=53) and those exhibiting 
bleeding on probing and at least four teeth with a prob-
ing depth (PD) >4 mm were entered to the chronic peri-
odontitis group (Group CP; n=53). Chronic periodontitis 
was defined according to the criteria established by the 
American Academy of Periodontology (1,3). 
- Molecular Blood Analysis (Linfocyte Isolation and 
DNA Extraction)
Blood was centrifuged at 7000 rpm x 5min for the mo-
lecular analysis, separating the plasma and recuperating 
the leucocytes, and after that 3 ml of hypotonic solution 
TE 20:5 was added. This process was repeated until the 
precipitation could get a white colour, which was then 
embedded in 200ul of TE 20:5. Once obtained, it was 
freezed at -20ºC and then thawed at 54ºC. Afterwards 
22.5ul of a SDS 10% solution was added with a final 
concentration of 1.13%, as well as 5ul of proteinase K at 
500ug/ml was aggregated. It was then mixed and incu-
bated at 54ºC, for an entire night. At a latter point 500 
ul of chloroform solution of isopropilic alcohol 24:1 Ice 
was added, agitated for a 10min period. After that this 
solution of centrifuged at 5rpm for 10 min, recuperat-
ing the supernatant on other container with precautions 
for not touching the interphase. At this time, 174ul of 
Ammonium Acetate with a final concentration of 7M. 
After the mix a floating fluff was obtained. It was then 
centrifuged at 14000 rpm x 3 opted and then 1ml of a 
70% solution of ethanol was added, so as to eliminate 
the remaining proteins and the ammonium acetate. A 
buffer TE 20:1 of 50 to 500 ul was added. In order to 
preserve the DNA sample, it was placed on 4ºC for 1 
week, before it was stored at -20ºC.
- Polymerase chain reaction-restriction fragment length 
polymorfism (PCR-RFLP)
Samples were genotyped by PCR-RFLP method for IL-
10 -1082. According to the procedures reported by Brett 
et al. (24), PCR was performed in a final volume of 50ul 
containing 100ng Genomic DNA, 20mM Tris-Hcl (pH 
- 8.4), 2mM of MgCL2, 0.2 mM of every deoxynucle-
otide (dNTP) (New England Labs Inc., Ipswich, MA, 
USA) and 0.8 uM of every primer (5′-TCT GAA GAA 
GTC CTG ATG TCA CTG-3′ y 5′- ACT TTC ATC TTA 
CCT ATC CCT ACT  TCC-3′ - (Fermentas, Thermo 
Fisher Scientific Inc, Waltham, MA, USA), and 1.5 U 
of Taq DNA polymerase. Then, the amplification pro-
tocol was conducted as follows : 1) Pre-PCR (95°C for 
4 minutes); 2)  PCR (40 cicles:  95°C for 1 minute, 55°C 
for 1 minute, and 72°C for 1 minute); and 3) elongation 
(72°C for 1 minute, 4°C  for  indefinite). After these pre-
vious procedures, DNA was digested with restriction 
fragments and separated by size using electrophore-
sis. RFLP amplification protocols were directed with 
the restriction enzyme Mnll, as well as the fragments 
was visualized on an agarose gel at 3%. The expect re-
sults were: 1) allele G: 28bp/58bp/110; and 2) allele A: 
58bp/138bp.
- Statistical analysis
Descriptive statistics were used to synthetize collected 
data using the subject as the unit of analysis. Statistical 
analysis of the clinical parameters was carried out to 
compare the differences between groups using the Two 
Sample t-test. Differences between groups in terms of 
the distribution of frequencies of genotypes and allele 
carriage (G or A) in healthy (H) and chronic periodon-
titis (CP) subjects were assessed by the Chi-Square (χ2) 
test. Additionally, the chance associated with individual 
or combined genotypes was calculated as the odds ra-
tio (OR), with 95% confidence intervals (CI). A signifi-
cance level for rejection of the null hypotheses was set 
at α= 0.05. The analyses were performed using a soft-
ware package (NCSS 2007 (Number Cruncher Statisti-
cal System, NCSS, Kaysville, UT, USA).
Results
- Subject characteristics
Differences in clinical measurement between subjects 
with or without CP are depicted in table 1. There were 
statistically significant differences between H and CP 
groups for the mean BoP, mean CAL and mean PD (p 
< 0.00001). These differences showed that the matching 
based on these two groups was adequate.
- Genotype and allele frequencies
The distribution of frequencies of genotypes and allele 
carriage of the IL-10 -1082 in subjects with or without 
CP is described in table 2. The Chi-Square test found a 
statistically significant imbalance of genotypes between 
Outcome Healthy Periodontium
Chronic 
Periodontitis
Two Sample 
t-Test
BoP  (%) 26.1 (4.6) 70.7 (7.2) P < 0.00001 
CAL (mm) 2.7 (0.4) 6.1 (2.1) P < 0.00001 
PD   (mm) 2.5 (0.3) 5.8 (0.9) P < 0.00001 
Table 1. Clinical measurements: mean and standard deviation 
(SD).
BoP – bleeding on probing; CAL – clinical attachment level; PD 
– probing depth.
 -1082 Interleukin-10
SNPs  
genotype 
Chronic 
periodontits AA GA GG Total 
No 11 16 26 53 
Yes 22 18 13 53 
Total 33 34 39 106 
Table 2. Distribution of subjects according to -1082 interleukin-
10 gene polymorphism.
Chi-Square = 8.11; Degrees of Freedom = 2; Probability Level 
(p) =0.0172. 
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the groups of periodontally healthy patients and those 
with CP  (p = 0.0172). With respect to the association be-
tween CP, genotype and allele frequency, the ORs were 
estimated as following: 1) when OR>1, the genotype or 
the presence of at least one specific allele favored the 
development of CP; 2) when OR <1, the genotype or 
the presence of at least one specific allele favored the 
maintenance of a healthy periodontium. The prevalence 
of CP was significantly different between carriers of the 
AA and GG genotypes at position -1082 A/G in com-
parison to GA genotype. CP was significantly higher in 
subjects harboring at least one A allele at position -1082 
A/G (AA and GA genotypes) in comparison to patients 
with the GG genotype (OR = 2.96; CI: 0.52; 5.41; p = 
0.0099). Equally, subjects with the AA genotype were 
significantly linked to a diagnosis of CP (OR = 2.71; CI: 
0.38; 5.04; p = 0.0231). 
On the other hand, subjects presenting a healthy peri-
odontal status presented at least one G allele (GG or GA 
genotypes) in comparison with the AA genotype (OR 
= 0.37; CI: 0.05, 0.69; p = 0.0231). For subjects with the 
GG genotype, the same positive association was ob-
served (OR = 0.34; CI: 0.06, 0.62; p = 0.0099). In ad-
dition, there were no significant differences between 
groups amongst subjects with the GA genotype (OR = 
1.19; CI: 0.22, 2.16; p = 0.6774). 
Discussion
This study assessed the association between CP and the 
polymorphisms of the IL-10 promoter and in a Peruvian 
(Amerindian-Spanish) population. According to the re-
sults found by the statistical analyses applied, the sig-
nificant differences in clinical results showed that the 
selection of patients with or without CP was correctly 
performed. Regarding the distribution of frequencies of 
genotypes and allele carriage of the IL-10 -1082, these 
were not balanced between groups (p = 0.0172) and the 
following assumptions could be addressed: 1) subjects 
harboring at least one A allele seems to be more sus-
ceptible to CP when compared to subjects with the GG 
genotype; and 2) subjects harboring at least one G allele 
seems to be less susceptible to CP when compared to 
subjects with the AA genotype.
Moreover, differences between groups were not found 
for subjects with the GA genotype (P=0.6774). These 
outcomes are in line with data from other populations 
that evaluated the frequency of -1087 IL-10 gene poly-
morphism between subjects with or without CP (16,24-
26). Conversely, results from Chinese, Jordanian and 
Swedish did not show the same. For instance, Loo et al. 
(27) found that Chinese subjects with CP presented a 
significant lower frequency of a -1082 IL-10 AA geno-
type than those without CP (p < 0.001), with odds ratio 
of  6.5 for subject harboring at least one G allele (GG 
and GA genotypes) when compared with  AA genotype 
amongst subject with CP. As a result, these authors sug-
gested that the prevalence of subjects with a GG geno-
type is significantly lower in subjects without CP than 
in subjects with CP (28). Moreover, Berglundh et al. 
(15) reported similar results. They found that subjects 
with CP were positively associated to a GG genotype 
than subjects without CP (OR = 6.1). Indeed, it has been 
suggested that such contrasting outcomes could be as-
sociated to genotypic differences in cytokine genes 
between ethnically different populations (16). Further-
more, other environmental condition, such as smoking 
might explains contradictory outcomes (7,24). 
In addition, it has been suggested that the outcomes of 
previous studies that found positive associations between 
periodontal disease and GP might be produced by type 
1 errors. Schaefer et al. (28) performed a large-scale, 
replication study in which potential candidate genes of 
periodontitis were assessed, and no associations were 
identified. These authors also suggested that the lack of 
associations could be related to ethnical homogeneity 
of the studied populations. In this short communication 
an Amerindian-Spanish population was assessed for the 
first time, and it might be possible that a type I error 
may have occurred. Sample size calculation has been 
performed to avoid such a type of statistical error, but it 
might not has been enough to assess the real link of GP 
and CP; however, it might be argued that some genetic 
heterogeneity between distinct populations may allow 
that high-risk variants in the human genome might be 
present, and thus real associations may be present. As a 
result, these are important aspects for the present pre-
liminary study and require careful interpretation.
Within the limits of this study, the association of -1082 
interleukin-10 gene polymorphism with CP was as-
sessed for the first time in a Peruvian population. Based 
on the present results, it can be concluded that IL-10 
polymorphisms is not associated to CP. Conversely, 
subject with AA genotype seems to be an increased risk 
of developing CP.
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